Patient entry into randomized controlled trials of colorectal cancer treatment: Factors influencing participation

Surgery

Volumn 133, Issue 6, 2003, Pages 608-613

  Solomon, Michael J ^a   Pager, Chet K ^b   Young, Jane M ^b   Roberts, Rachael ^b   Butow, Phyllis ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER RESEARCH; CANCER RISK; CLINICAL RESEARCH; CLINICAL TRIAL; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SURGEON;

EID: 0037782136     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2003.119     Document Type: Article

References (30)

1. Solomon MJ, McLeod RS. Should we be performing more randomized controlled trials evaluating surgical operations? Surgery 1995;118:459-67.
2. McCulloch P, Taylor I, Sesako M, Lovett B, Griffin D. Randomised trials in surgery: problems and possible solutions. Br Med J 2002;324:1448-51.
3. Solomon MJ, McLeod RS. Surgery and the randomised controlled trial: past, present and future. Med J Aust 1998;169:380-3.
4. Gattellari M, Ward JE, Solomon MJ. Randomized, controlled trials in surgery: perceived barriers and attitudes of Australian colorectal surgeons. Dis Colon Rectum 2001;44:1413-20.
5. Solomon MJ, McLeod RS. Clinical studies in surgical journals: have we improved? Dis Colon Rectum 1993;36:43-8.
6. Solomon MJ, Laxamana A, Devore L, McLeod RS. Randomized controlled trials in surgery. Surgery 1994;115:707-12.
7. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol 1999;52:1143-56.
8. Verheggen F, Nieman F, Ruud J. Determinants of patient participation in clinical studies requiring informed consent: why patients enter a clinical trial. Patient Educ Couns 1998;35:111-25.
9. Slevin M, Mossman J, Bowling A, Leonard R, Steward W, Harper P, et al. Volunteers or victims: patients' views of randomised cancer clinical trials. Br J Cancer 1995;71:1270-4.
10. Mattson ME, Curb JD, McArdle R. Participation in a clinical trial: the patients' point of view. Control Clin Trials 1985;6:156-67.
11. Llewelyn-Thomas HA, McGreal MJ, Thiel EC, Fine S, Erlichman C. Patient's willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med 1991;32:35-42.
12. Llewellyn-Thomas HA. Patients health care decision making: a framework for descriptive and experimental investigations. Med Decis Making 1995;15:101-6.
13. Taylor KM, Margolese RG, Soskolne CL. Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med 1984;10:1363-7.
14. Keshava A, Solomon MJ, Findlay M, Butow P, Salkeld G, Roberts R. Treatment of colorectal cancer: what do patients want? ANZ J Surg 2002;72(Suppl):A23.
15. Ling J, Rees E, Hardy J. What influences participation in clinical trials in palliative care in a cancer centre? Eur J Cancer 2000;36:621-6.
16. Bevan EG, Chee LC, McGhee SM, McInnes GT. Patients' attitudes to participation in clinical trials. Br J Clin Pharmacol 1993;25:204-7.
17. Barofsky I, Sugarbaker PH. Determinants of nonparticipation in randomized controlled trials for the treatment of sarcomas. Cancer Clin Trials 1979;2:237.
18. Finn R. Surveys identify barriers to participation in clinical trials. J Natl Cancer Inst 2000;92:1556-8.
19. Sawka CA, Pritchard KI. Can improved communication increase patient participation in randomised clinical trials? Eur J Cancer 2001;37:297-9.
20. Ellis PM. Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Ann Oncol 2000;11:939-45.
21. Simes RJ, Tattersall M, Coates AS, Raghavan D, Solomon HJ, Smartt H. Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment of cancer. Br Med J 1986;293:1065-8.
22. MacKillop WJ, Ward GK, O'Sullivan B. The use of expert surrogates to evaluate clinical trials in non-small cell lung cancer. Br J Cancer 1986;54:661-7.
23. Moore MJ, O'Sullivan B, Tannock IF. How expert physicians would wish to be treated if they had genitourinary tract cancer. J Clin Oncol 1988;6:1736-45.
24. Kennelly C, Bowling A. Suffering in deference: a focus group study of older cardiac patients' preferences for treatment and perceptions of risk. Qual Health Care 2001;10(Suppl 1):i23-8.
25. Robinson A, Thomson R. Variability in patient preferences for participating in medical decision making: implication for the use of decision support tools. Qual Health Care 2001;10(Suppl 1):i34-8.
26. Till JE, Sutherland HJ, Meslin EM. Is there a role for preference assessments in research on quality of life in oncology? Qual Life Res 1992;1:31-40.
27. Fagerlin A, Ditto PH, Danks JH, Houts RM, Smucker WD. Projection in surrogate decisions about life-sustaining medical treatments. Health Psychol 2001;20:166-75.
28. Covinsky KE, Fuller JD, Yaffe K, Johnston CB, Hamel MB, Lynn J, et al. Communication and decision-making in seriously ill patients: findings of the SUPPORT project. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc 2000;48(5 Suppl):S187-93.
29. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987;317:141-5.
30. Weijer C, Shapiro SH, Cranley Glass K. For and against: clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial. Br Med J 2000;321:756-8.